# The Akkermansia Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/the-akkermansia-company

- Industry: Biotechnology
- Headquarters: Mont-Saint-Guibert, Belgium
- Website: www.theakkermansiacompany.com
- Total disclosed funding: $8.9M
- Latest round: Series A (Sep 12, 2018)
- Investors on record: 5

## About

Based in Mont-Saint-Guibert, Belgium, and founded in 2016, The Akkermansia Company, formerly known as A-Mansia Biotech S.A., operates as a biotechnology company that offers dietary supplements which include Akkermansia. The company was founded by Willem M. de Vos and Patrice D. Cani. In September 2018, the company raised EUR 18 million in series A funding co-led by Seventure, SRIW, and Vives.

The firm develops food supplements based on pasteurized Akkermansia. The food supplement offered helps in weight management and controls blood pressure. The tablets contain ingredients such as EGCG green tea which helps in weight control, chromium which helps in the maintenance of normal blood glucose levels, and vitamin B2 which maintains mucous membranes. The tablets should be stored at room temperature in a dry place and the recommended dosage is 1 tablet per day.

## Funding rounds

- Series A, Sep 12, 2018, $1.2M — Innovation Industries
- Series A, May 3, 2018, $7.8M — Seventure Partners, Vives, Société Régionale d'Investissement de Wallonie, Invest.BW

## Investors

- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series A
- Vives (https://capitalatlas.ai/funds/vives) — Series A
- Société Régionale d'Investissement de Wallonie — Series A
- Invest.BW (https://capitalatlas.ai/funds/invest-bw) — Series A
- Innovation Industries (https://capitalatlas.ai/funds/innovation-industries) — Series A